These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. Jewett A; Cavalcanti M; Bonavida B J Immunol; 1997 Nov; 159(10):4815-22. PubMed ID: 9366406 [TBL] [Abstract][Full Text] [Related]
48. Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia. Deng G; Zheng X; Zhou J; Wei H; Tian Z; Sun R J Biol Chem; 2015 Sep; 290(37):22474-84. PubMed ID: 26198633 [TBL] [Abstract][Full Text] [Related]
49. Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Morgan MA; Kloos A; Lenz D; Kattre N; Nowak J; Bentele M; Keisker M; Dahlke J; Zimmermann K; Sauer M; Heuser M; Schambach A Viruses; 2021 Jul; 13(7):. PubMed ID: 34372571 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death. Kim HR; Kim K; Lee KH; Kim SJ; Kim J Clin Exp Immunol; 2008 May; 152(2):336-44. PubMed ID: 18336591 [TBL] [Abstract][Full Text] [Related]
51. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. Khaznadar Z; Henry G; Setterblad N; Agaugue S; Raffoux E; Boissel N; Dombret H; Toubert A; Dulphy N Eur J Immunol; 2014 Oct; 44(10):3068-80. PubMed ID: 25041786 [TBL] [Abstract][Full Text] [Related]
52. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925 [TBL] [Abstract][Full Text] [Related]
53. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48. Zhang T; Fang Q; Liu P; Wang P; Feng C; Wang J J Transl Med; 2022 Sep; 20(1):394. PubMed ID: 36058936 [TBL] [Abstract][Full Text] [Related]
54. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity. She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207 [TBL] [Abstract][Full Text] [Related]
55. NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML. Schlegel P; Ditthard K; Lang P; Mezger M; Michaelis S; Handgretinger R; Pfeiffer M J Immunol Res; 2015; 2015():473175. PubMed ID: 26236752 [TBL] [Abstract][Full Text] [Related]
56. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade. Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023 [TBL] [Abstract][Full Text] [Related]
57. TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells. Nieda M; Nicol A; Koezuka Y; Kikuchi A; Lapteva N; Tanaka Y; Tokunaga K; Suzuki K; Kayagaki N; Yagita H; Hirai H; Juji T Blood; 2001 Apr; 97(7):2067-74. PubMed ID: 11264173 [TBL] [Abstract][Full Text] [Related]
58. An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia. Koerner SP; André MC; Leibold JS; Kousis PC; Kübler A; Pal M; Haen SP; Bühring HJ; Grosse-Hovest L; Jung G; Salih HR Leukemia; 2017 Feb; 31(2):459-469. PubMed ID: 27435001 [TBL] [Abstract][Full Text] [Related]
59. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967 [TBL] [Abstract][Full Text] [Related]
60. CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Coles SJ; Wang EC; Man S; Hills RK; Burnett AK; Tonks A; Darley RL Leukemia; 2011 May; 25(5):792-9. PubMed ID: 21274000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]